Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
Auriga Maintains a 'Buy' on Herbalife (HLF); Spark From Additional Licenses in China
-
Auriga Reiterates a 'Buy' on Herbalife (HLF); Shares Still Offer Material Upside
-
Streetinsider.com's Hot Lunchtime Reads 05/09: (S) (kkd) (WEN) (GLD) (TPX) (HLF)
-
Auriga Maintains 'Buy' on Herbalife (HLF); Takeaways From Analyst Meeting
-
Herbalife (HLF) Shares Continue Lower Despite Numerous 'Buy the Weakness' Calls
-
UPDATE - Auriga Upgraded Herbalife (HLF) to Buy; Accumulate Shares on Dip
-
Notable Analyst Rating Changes 05/02: (GNW) (ACI) (HLF) Upgraded; (RSH) (COP) (EQT) Downgraded
-
Auriga Upgrades Herbalife (HLF) to Buy
-
Auriga Maintains a 'Hold' on Herbalife (HLF); Beating Sustained Growth
-
Auriga Maintains a 'Hold' on Herbalife (HLF); Expect Improvement in 1Q
-
Auriga Reiterates a 'Hold' on Herbalife (HLF); Raising Numbers on Strong Q4
-
Auriga Starts Herbalife (HLF) at Hold, Sets Price Target at $50
